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INTRODUCTION
Leptin is a 16-kDa protein identified as the obese gene product
that plays a crucial role in body weight regulation (1). Leptin is
synthesized and secreted mainly by white adipose tissues, and its
plasma concentrations are proportional to adiposity in humans.
Leptin is also expressed in other organs including placenta, ovaries,
skeletal muscle, stomach, mammary epithelial cells, bone marrow,
pituitary gland, liver and the brain (2). Leptin controls various as-
pects of energy intake and expenditure by inhibiting appetite, sup-
pressing lipogenesis, modulating T-cell activity and the ovulatory
cycle, promoting angiogenesis and surfactant expression in type II
pneumocytes, regulating bone metabolism and inflammatory re-
sponses, and influencing the stress response (3, 4). As to the
effect of leptin on the stress response, its relationship with the
hypothalamo-pituitary-adrenal (HPA) axis and feeding has been
investigated into appreciable detail in experimental animals. The
complex action of leptin on the HPA axis in relation to both stress
adaptation and feeding may hold for vertebrates in general (5).
Leptin produced in the brain and particularly in the hypothalamus/
the arcuate can act on the paraventricular nuclei (PVN) to affect the
HPA-axis activity. Peripheral infusion of leptin before and during
restraint stress suppresses stress- induced corticosterone release
in rats (6). Injected leptin inhibits stress- induced anorexia and
behavioral deficits in rats (6). Thus, leptin is now considered to be a
stress-related hormone (7). However, its effects on the HPA axis
likely depends on the strength and the type of stressors.
The heat-shock proteins (HSPs) have a cytoprotective property
as intracellular chaperons, by which aberrantly folded or damaged
proteins in various stressful conditions are repaired and, if neces-
sary, degraded for cellular homeostasis (8, 9). A wide variety of
stresses, such as ischemia and inflammation, induce an increase in
the expression of HSPs, and particularly a stress- inducible HSP70
has been proved to exhibit a cytoprotective function both in vitro
and in vivo (10). Geranylgeranylacetone (GGA) is an acyclic iso-
prenoid compound, which has been widely used as an anti -ulcer
agent without any serious adverse effects (11). GGA is known as a
non-toxic chaperone inducer that specifically induces HSPs, espe-
cially HSP70 in various tissues, including gastric mucosa (10), liver
(12), and the brain (13). Recent studies have also implicated that
GGA-mediated HSP105 induction may provide a novel therapeutic
strategy for depression- like behavior (14). These reports suggest
that administration of GGA may have a protective effect against
several injury models and human diseases. There is one report
showing the effect of GGA on leptin secretion. Long-term treat-
ment of GGA decreases body weight gain and serum leptin levels in
high-fat feeding mice (15). However, it has not been examined
whether GGA could modulate leptin secretion under stressful
conditions.
Here, we examined whether oral GGA administration modu-
lated the production of leptin in epididymal adipose tissue and
ghrelin in gastric mucosa using a restraint stress model of mice.
MATERIALS AND METHODS
Animals
Male wild- type C57BL/6J mice were purchased from Charles
River Laboratories (Kanagawa, Japan). All mice were treated in
accordance with the National Institute of Health Guide for the Care
and Use of Laboratory Animals, and all procedures were approved
by the Animal Care Committee of Tokushima University Graduate
School. Mice were bred and maintained under specific pathogen-
free conditions (SPF) at constant temperature of 232 and 65%
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humidity on a 12-h dark- light cycle (lights on at 08 : 30). All mice
were free to access a standard rodent chow (Oriental Yeast, Tokyo,
Japan). Body weights and food intakes of mice were measured at
10 : 00 every three days before starting the experimental manipula-
tions.
GGA treatment and restraint stress
At 8 or 9 weeks of age, male mice were taken a standard rodent
chow powder (control diet ; Oriental Yeast) or the powder supple-
mented with GGA granule (provided by Eisai Co. Tokyo Japan).
GGA granules were mixed with the chow powder at a concentra-
tion of 0.5%. Mice at 8 or 9 weeks of age (average weight of 24 g)
consumed 4.22 g of the chow per day. The actual average intake of
GGA was calculated to be 0.16 g per kg body weight per day. This
dose was shown to induce HSP70 in mouse gastric mucosa (16).
After mice took GGA-supplemented chow or control chow for 10
days, they were exposed or left unexposed to restraint stress. Re-
straint stress was done by placing mice in a restrainer (a rounded
plastic tube 27 mm in diameter) for 2 h one time or once a day for 5
consecutive days. During the restraint stress, mice continued to
take GGA-supplemented or control chow powders and their body
weights and food intakes were measured daily at 10 : 00 prior to the
stress. Before and immediately after a single or 5-time restraint
stress, mice were sacrificed under deep anesthesia with diethyl
ether. Blood was collected by cardiac puncture. At the same time,
epididymal adipose tissue and stomach were also collected from
the mice. After washing with cold saline, gastric mucosa was re-
moved by a slide glass. Removed epididymal adipose tissue and
gastric mucosa were stored at -80 until analysis. For mRNA
measurements, epididymal adipose tissue and gastric mucosa were
immediately incubated with the RNA later stabilization reagent
(Ambion, Austin, TX) for 24 h and then stored at -80 until
analysis.
Quantitative real-time reverse transcription (RT)-PCR
Total RNA was extracted from the stored epididymal adipose
tissue and gastric mucosa using RNAiso Plus reagent (Takara,
Otsu, Japan).ContaminatingDNAwasremovedwithdeoxyribonu-
clease using the TURBO DNA-freeTM kit (Ambion). Complemen-
tary DNA was prepared from total RNA (2 µg) of epididymal adi-
pose tissue and gastric mucosa using oligo dT and random primer
using the ReverTra Ace (Toyobo, Osaka, Japan). Amounts of leptin
and hspa1mRNAs in epididymal adipose tissue and ghrelinmRNA in
gastric mucosa were measured by real - time reverse transcription
(RT)-PCR. Glyceraldehyde 3-phosphate dehydrogenase (gapdh)
mRNA was used as an endogenous quantitative control. The follow-
ing primer sets were used to amplify leptin mRNA, 5’ -CAGGAT-
CAATGACATTTCACACA-3’ (forward) and 5’ -GCTGGTGAGGA-
CCTGTTGAT -3’ (reverse) ; ghrelin mRNA, 5’ -AAGAAGCCACC-
AGC-3’ (forward) and 5’ -ATCGAAGGGAGCATTGAAC -3’ (re-
verse) ; hspa1 mRNA, 5’ -GTGTGAGAGGGCCAAG-3’ (forward)
and 5’ -ATGCCCTCGAACAGAG-3’ (reverse) ; gapdh mRNA, 5’ -
AACTTTGGCATTGTGGAAGGTAAAC-3’ (forward) and 5’ -GG-
ATGCAGGGATGATGTTCT -3’ (reverse). Real - time RT-PCR was
performed by the ABI-PRISM 7500 system using the SYBR Green
detection assay (Applied Biosystems, Foster City, CA).
Measurements of plasma leptin and corticosterone levels
Before and immediately after the restraint stress, mice were
anesthetized with diethyl ether, and blood was collected in EDTA-
containing tubes. Plasma was separated by centrifugation at 7,500 g
for 5 min at 4 and stored at -80 until measurements using
enzyme-linked immunosorbent assay (ELISA) systems. Plasma
leptin and corticosterone levels were analyzed according to the
manufacturer’s protocols using Quantikine ELISA (R&D Systems,
Minneapolis, MN) and Corticosterone ELISA kit (Enzo Life Sci-
ences, Farmingdale, NY), respectively.
Immunoblot analysis
Epididymal adipose tissues were homogenized in RIPA buffer
(Cell Signaling Tech., Danvers, MA) containing a protease and
phosphatase inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) and
centrifuged at 10,000 g for 5 min at 4. The supernatants (20 µg
protein) were separated by sodium dodecyl sulfate -polyacrylami-
de gel electrophoresis in a 15% polyacrylamide gel and trans-
ferred to a polyvinylidene difluoride membrane (BioRad, Hercu-
les, CA). After blocking with 5% non-fat drymilk (Cell Signaling
Tech.), the membranes were incubated overnight at 4 with a
rabbit polyclonal anti - leptin antibody (1 : 1000 dilution ; GeneTex,
Irvine, CA) or a monoclonal antibody for anti -mouse HSP70 (1 :
1000 ; StressMarq, Victoria, Canada) or for anti -mouse beta actin
(1 : 5000 ; Santa Cruz Biotech., Santa Cruz, CA). After incubated
with the corresponding second antibodies, bound antibodies were
detected by an enhanced chemiluminescence Western blotting de-
tection system (Amersham Pharmacia, Piscataway, NJ). The intensi-
ties of the bound antibodies were quantified by using the Image
Studio software (LI-COR, Lincoln, NE).
Statistical Analysis
All data were presented as the meanSD from at least three
independent experiments. Statistical comparisons between differ-
ent conditions were done by unpaired t - test using the GraphPad
Prism program (GraphPad Software Inc., San Diego, CA). P val-
ues of less than 0.05 were regarded as statistically significant.
RESULTS
Effects of GGA and restraint stress on food intakes and body
weight changes
Body weights of GGA or control groups were measured at 10 : 00
every three days before restraint stress and every day during the
stress, and daily changes are shown in Figure 1a. Averages of daily
food intakes of the mice are also shown in Figure 1b. There was no
significant change in body weight gain between GGA and control
groups before and during the stress (Figure 1a). Exposure to 2-h
restraint stress once a day for 5 consecutive days (5-time restraint
stress) inhibited body weight gain similarly in both GGA and con-
trol groups (Figure 1a). On the other hand, 5- time restraint
stress significantly reduced daily food intakes in GGA-treated
mice, but not in control mice (Figure 1b). As a result, GGA-treated
mice significantly decreased daily food intake compared with con-
trol mice during the stress period.
Effects of GGA and restraint stress on plasma corticosterone
levels
To confirm that the restraint stress actually evoked stress re-
sponses in the mice and to examine whether GGAmodulated the
responses, we first measured plasma corticosterone levels before
and immediately after a single or 5-time restraint stress. Figure 2a
shows that either one- or 5-time restraint stress similarly increased
plasma corticosterone levels. GGA administration did not change
plasma corticosterone levels before and after the stress. Thus, in
our experimental conditions, GGA did not modulate the plasma
corticosterone response and did not improve the stress- induced
decline of body weights. However, we found that GGA administra-
tion significantly reduced food intake during the stressful situation.
Effects of GGA and restraint on plasma leptin levels
Although it has been consistently demonstrated that GGA ex-
hibits protective actions against cell and tissue injuries in vari-
ous types of stress models, we were interested in the enhanced
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reduction of food intake in GGA group exposed to restraint stress,
since we had expected that an anti -stress compound GGA rather
improved the stress- induced appetite loss. We therefore tried to
reveal the mechanism for this effect.
First we examined the changes in plasma leptin levels. Leptin is
known to be one of the potential factors for the regulation of energy
intake when exposed to stress (3). As shown in Figure 3a, in control
mice, a single restrain stress rapidly decreased plasma leptin con-
centrations and remained to be low after 5-time restraint stress.
Mice treated with GGA for 10 days significantly increased plasma
leptin levels before exposure to restraint stress, compared with
control mice (Figure 3a). In addition, a single restraint stress did
not significantly decreased plasma leptin levels in GGA-treated
mice, and the values were significantly higher than those in control
mice (Figure 3a). However, GGA could not prevent the decline of
plasma leptin concentrations when restraint stress was repeated
for 5 consecutive days (Figure 3a).
Effect of GGA on leptin mRNA and protein expression in epididy-
mal adipose tissues
White adipose tissues are a major source of circulating leptin. We
also examined the effect of GGA on leptin by measuring leptin
mRNA and protein levels in epididymal adipose tissues. In control
mice, a single restraint stress did not change leptinmRNA levels,
while the repeated stress for 5 days significantly decreased the
mRNA levels (Figure 3b). Daily administration of GGA for 10 days
significantly increased expression levels of leptin mRNA before the
stress, which was consistent with increased levels of circulating
leptin after the GGA administration (Figure 3a). This increase was
cancelled after a single restraint stress, and 5-time restraint stress
deceased leptinmRNA levels in epididymal adipose tissues, simi-
larly observed in control mice (Figure 3b). When leptin protein
levels were compared between GGA-treated and untreated control
mice, GGA rather increased leptin in epididymal adipose tissues
after a single restraint stress. Consequently, the levels were signifi-
cantly higher than those of control mice (Figure 3c).
Figure 1. Effects of GGA and restraint stress on daily food intake and
body weight changes. (a) Mice were treated with GGA (0.16 g per kg
body weight per day) for 10 days or left untreated (control mice). These
mice were exposed to a single 2 -h restraint stress or 2 -h restraint stress
once a day for 5 consecutive days (5 - time restraint stress). Body
weights of GGA-treated or untreated control mice were measured every
three days before restraint stress and every day during the stress. Values
are meansSD (n = 20). (b) Food intakes were also measured every
three days before restraint stress and every day during the stress.
MeansSD of daily food intakes are shown. Numbers of mice are indi-
cated in the parentheses.*P0.05 by unpaired t - test.
Figure 2. Effects of GGA and restraint stress on plasma corticosterone
levels. GGA-treated or untreated control mice were sacrificed under
general anesthesia with diethyl ether before the stress at 10 : 00 or
immediately after a single or 5 - time restraint stress at 12 : 00. Blood was
collected by cardiac puncture. Plasma corticosterone levels were meas-
ured using an ELISA kit. Values are meansSD. Numbers of mice are
indicated in the parentheses. **P0.05 by unpaired t - test.
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Effects of GGA on HSP70 induction in epididymal adipose tissues
It has been demonstrated that GGA could induce HSP70 in
rodent gastric mucosa (10). However, effect of GGA on white
adipose tissues has not yet been documented. We examined
whether GGA acted on epididymal adipose tissues and induced
HSP70. As shown in Figure 4a, a single restraint stress did not
significantly stimulate hspa1 mRNA expression in epididymal adi-
pose tissues of control mice, while 5-time exposure to restraint
stress significantly increased hspa1 mRNA levels (Figure 4a). GGA
treatment alone did not affect hspa1mRNA expression, but it sig-
nificantly augmented hspa1 mRNA expression after a single re-
straint stress (Figure 4a). However, protein levels of HSP70 were
not significantly increased in GGA-treated mice before and after
the restraint stress (Figure 4b).
Thus, GGA treatment appeared to actually act on epididymal
adipose tissues and prime them for accelerated hspa1mRNA induc-
tion under the stressful situation.
Effect of GGA on ghrelin mRNA expression in stomachs
We also examined the effect of GGA administration on ghrelin
production. We could not detect significant amounts of ghrelin in
peripheral blood using commercially available ELISA kits. We
therefore measured ghrelin mRNA levels in gastric mucosa. As
shown in Figure 5, a single or 5-time restraint stress did no change
ghrelin mRNA levels in gastric mucosa of control mice. Daily ad-
ministration of GGA for 10 days significantly reduced ghrelin
mRNA levels in gastric mucosa. After 5- time exposure to restraint
stress, ghrelinmRNA levels were significantly increased in GGA-
treated mice and returned to the baseline level.
DISCUSSION
We report here that a chaperone inducer GGA may modulate
energy intake and expenditure under stressful conditions. GGA
activates heat shock factor 1 and exert cytoprotective actions in
various organs exposed to ischemia/reperfusion or insults through
Figure 3. Effects of GGA and restraint stress on levels of plasma
leptin or its mRNA and protein in epidydimal adipose tissues. (a) Blood
was collected from GGA-treated or untreated control mice before or after
exposure to a single or 5 - time restraint stress. Plasma leptin levels were
measured using an ELISA kit.*P 0.05.**P 0.05. (b) Epidydimal
adipose tissues were also collected from the mice at the indicated time
points. Total RNA was extracted from the tissues and leptin mRNA levels
were measured by real - time RT-PCR. Gapdh mRNA was used as an
endogenous quantitative control. Values are meansSD. Numbers of
mice assayed are indicated in the parentheses.*P0.05.**P0.05. (c)
The collected epidydimal adipose tissues collected from GGA-treated or
control mice before or after a single restraint stress were also subjected to
Western blot analysis using an anti - leptin antibody. The levels of leptin
were standardized using CBB (Coomassie Brilliant Blue) -stained actin
band. Values in the left panel are meansSD. Numbers of mice
assayed are indicated in the parentheses.**P 0.05. Representative
Western blot data are shown in the right panel.
Figure 4. Effects of GGA and restraint stress on hspa1 mRNA and
HSP70 levels in gastric mucosa. (a) Gastric mucosa was prepared from
GGA-treated or untreated control mice before or after exposure to a
single or 5 - time restraint stress. Total RNA was extracted and hspa1 mRNA
levels were assayed by real - time RT-PCR. Gapdh mRNA was used as an
endogenous quantitative control. Values are meansSD. Numbers of
mice assayed are indicated in the parentheses.*P0.05.**P0.01.
(b) Soluble proteins were prepared from gastric mucosa of GGA-
treated or untreated control mice before or after exposure to a single
restraint stress. HSP70 levels were measured by Western blot analysis
using an ant -HSP70 antibody. The levels of HSP70 were standardized
using CBB-stained actin band. Values in the left panel are meansSD.
Numbers of mice assayed are indicated in the parentheses. Representative
results are shown in the right panel.
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induction of HSPs particularly HSP70 (9). At the same time,
Adachi et al. reported that GGA improved glucose metabolism and
reduced adiposity in an animal model of type 2 diabetes (15). In
addition, GGA can pass through blood brain barrier and affect the
central nervous system (17). It was showed that orally adminis-
tered GGA improved not only cognitive function but also reduced
the pathological phenotypes in Alzheimer’s model mice (17).
These results implicated that GGA might improve stress-associated
metabolic and mental dysfunctions. We show here for the first time
that GGA could act on white adipose tissues and enhance the induc-
tion of hspa1 mRNA when exposed to restrain stress in mice. More-
over, we found that GGA modulated leptin production from the
white adipose tissue.
Stress activates multiple neural and endocrine systems to re-
spond to and survive in threatening environments. The cortico-
tropin-releasing factor (CRF) system is a primary initiator of this
integrated response, which includes activation of the sympathetic
nervous system and the HPA axis. A typical energetic response to an
acute stressor is inhibition of food intake, increased heat produc-
tion, and sustained changes in body weight, behavior, and HPA
reactivity, while these responses are varied depending on the
nature and severity of the stressor. The effect of chronic psycho-
logical stress is more variable. However, few stress experiments
focus on energy balance. More information on the phenotype of
both humans and animal models during and after exposure to
acute or chronic stress is needed to understand mechanisms that
control energy intake and body weight under stressful conditions.
Central and peripheral injections of CRF (18, 19) suppress food
intake through peripheral sensory systems independent of direct
central modulation of anorexigenic or orexigenic factors. Gluco-
corticoids also have a potential to modulate food intake. Low
doses of glucocorticoid stimulate food intake by facilitating orexi-
genic activity of neuropeptide Y (NPY) and norepinephrine in the
PVN (20). By contrast, high doses of corticosterone suppress food
intake, possibly through glucocorticoid- induced insulin release,
which inhibits NPY expression (21). In our experimental condi-
tions, we could not detect any difference in circulating corticoster-
one levels between GGA-treated and untreated control mice before
and after exposure to the restraint stress, indicating that GGA did
not significantly modulate the reactivity of the HPA axis. We there-
fore focused on a peripheral anorexigenic (leptin) and orexigenic
(ghrelin) factors.
In control mice, a single exposure to 2-h restraint stress rapidly
decreased circulating leptin concentrations without changing its
protein and mRNA levels in epididymal adipose tissues. A repeti-
tion of the same stress for 5 consecutive days downregulated leptin
mRNA expression in the tissues and circulating leptin continued to
be low. These results suggest that psychological stress may ac-
celerate consumption of circulating leptin and then down-regu-
late leptin expression when it was repeated. In our experimental
conditions, the repetition of the stress for 5 consecutive days com-
pletely blocked daily weight gain without changing daily food in-
take in control mice. This leptin response may be a compensa-
tory for the stress- induced weight loss. In contrast, daily ad-
ministration of GGA for 10 days before the stress significantly in-
creased plasma leptin and its mRNA levels in epididymal adipose
tissues without changing daily food intake and body weight gain.
When GGA-treated mice were exposed to restraint stress, they
were resistant to the stress- induced declines of circulating leptin
and leptin mRNA expression in epididymal adipose tissues. Al-
though GGA-induced up-regulation of leptin did not significantly
reduced food intake before the stress, the maintenance of leptin
levels may be associated with an additional decline of food intake,
which was observed under repeated restraint stress in GGA-treated
mice. On the other hand, there was no difference in daily body
weight changes between GGA-treated and control mice in the pre-
sent experimental conditions.
Leptin plays a central role in controlling appetite and weight in
both rodents and humans. This hormone also regulates the four
main hypothalamo-pituitary-peripheral axesadrenal, thyroid,
gonadal, and growth hormone axesat different levels (22). As to
the HPA axis, leptin suppresses glucocorticoid secretion during
stress-related activation of the adrenal axis. In fact, a systemic in-
jection of leptin produced a significant attenuation in plasma lev-
els of corticosterone in immobilized animals (6). Rats exposed
to chronic stress showed decreased basal levels of leptin and sys-
temic administration of leptin can reverse depression- like behav-
iors in these animals (23). As psychiatric disorders like depression
are frequently associated with hypercortisolism, leptin is proposed
to exert anti -depressant- like effects due to its inhibition of chroni-
cally overactive HPA axis function. The association of low leptin
levels and developing depression has been proposed in humans
(24). Although there are inconsistent results regarding leptin
measurement in major depression (25, 26), there seem to be sex
differences in plasma leptin measures between depressive patients
and healthy controls (26, 27). In women, low leptin levels are associ-
ated with increased symptoms of depression and there is an inverse
relationship between leptin levels and anxiety symptoms inde-
pendent of body weight (27). Thus, leptin status of depressed pa-
tients could serve as a prognostic marker for therapy response.
Although the inhibitory effect of leptin on the HPA axis has been
suggested to mediate anti -depressant- like effects in animal mod-
els. In case of our study, administration of GGA suppressed de-
cline of plasma leptin levels when exposed to the restrain stress,
while it could not suppress the elevation of corticosterone.
We also examined changes in circulating ghrelin. Ghrelin is an
appetite regulatory hormone mainly produced in the stomach (28).
Studies in rodents demonstrated potent stimulatory effects on food
intake, increased body weight gain, and increased adiposity with
either peripheral or central administration of ghrelin (29-31). The
Figure 5. Effects of GGA and restraint stress on ghrelin mRNA
levels in gastric mucosa. Gastric mucosa was prepared from GGA-
treated or untreated control mice before or after exposure to a single or 5 -
time restraint stress. Total RNA was prepared from gastric mucosa and
ghrelin mRNA levels were assayed by real - time RT-PCR. Gapdh mRNA
was used as an endogenous quantitative control. Values are means
SD. Numbers of mice assayed are indicated in the parentheses. *P0.05.
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orexigenic hypothalamic arcuate neuropeptide (NPY)/Agouti -re-
lated peptide-expressing neurons are a prominent direct target of
ghrelin action (32). Plasma ghrelin is negatively correlated in the
short term with feeding status and in the long term with body mass
index (33). Ghrelin also acts in a protective manner to counter
anxiety and depression during stressful conditions. Administered
ghrelin induces both antidepressant- like and anxiolytic- like be-
haviors in mice. Moreover, different forms of psychosocial stress
lead to plasma ghrelin elevation in rodents and humans (34, 35),
suggesting its role as a mediator of stress-based eating behaviors
(34, 36). An activated ghrelin system may not only engage anti -
depressant- like and anxiolytic behaviors that help motivate hun-
gry, prey-susceptible individuals, but also help minimize the devel-
opment of any related self -destructive behaviors. Daily administra-
tion of GGA for 10 days significantly reduced ghrelin mRNA levels in
gastric mucosa without changing daily food intake and body weight
gain. When the GGA-treated mice were exposed to the repeated
restraint stress, the reduction was cancelled and the ghrelin mRNA
levels significantly increased to the baseline level. We could not
measure plasma ghrelin levels, because there is no reliable anti-
body for measurement of each modified ghrelin proteins. It has
been suggested that the feeding response and body weight changes
mediated by ghrelin are likely to be dispensable when food avail-
ability is plentiful like our experimental conditions (37). Effects of
long-term administration of GGA on ghrelin as well as leptin pro-
duction and resultant changes in food intake and body weight
should be investigated.
We showed that GGA acted as a chaperon inducer on epididymal
adipose tissues under stressful condition. However, both leptin and
ghrelin levels were significantlyaffected by a ten-day treatment of
GGA (before stress) without significant induction of hspa1 mRNA
and HSP70 protein levels. There is a possibility that the change in
leptin and/or ghrelin was caused by not the chaperone but the
GGA itself through another signaling pathway.
Unfortunately we did not examine the effects of GGA on anxiety
and depression- like behaviors in the present study. At this time
point, pathophysiological meaning of the anorexigenic effect of
GGA is unknown. Particularly, it is unclear whether GGA-induced
decline of food intake in association with the maintenance of circulat-
ing leptin levels is advantageous to cope with the psychological
stress. However, considering to the effects of leptin and ghrelin on
mood, the maintenance of plasma leptin and ghrelin levels may be
beneficial for alleviation of anxiety and depressive mood under the
stressful situation. Further studies are needed to clarify these is-
sues.
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